GLP-1 weight-loss drug, whose full name is Glucagon-like peptide-1 receptor agonist. Initially, GLP-1 was a hormone secreted by the gastrointestinal tract mainly used for treating diabetes, but it has also been used to suppress appetite and control weight.
Executive Reshuffles: LLY, S and RY Companies in Focus
J&J Leads H1 Healthcare Deals as Big Pharma Dealmaking Returns: Report
Pfizer's "weight gain drug" has achieved positive experimental results and is expected to fill the current situation of "no available drugs" in the fatal disease course.
① Unlike weight loss drugs, pfizer monoclinal antibody drug ponegromab aims to reduce factors that suppress appetite in the brain; ② In the field of cancer, about 80% of patients are diagnosed with cachexia and are expected to die within a year. ③ So far, the FDA has not approved any drugs for the treatment of cachexia.
"Florida Discourages Use Of MRNA Covid Vaccines In Older Adults; In Updated Guidance To Health Care Providers, Florida Health Officials Advise That "Non-mRNA Covid-19 Vaccines And Treatment" Should Be Prioritized" - NBC News
Novavax COVID-19 Vaccines Now Available
Eli Lilly Analyst Ratings